Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases - Poll - MDSpire

Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases

  • By

  • Sukwoo Hong

  • Hirokazu Takami

  • Motoyuki Umekawa

  • Yuki Shinya

  • Hirotaka Hasegawa

  • Mariko Kawashima

  • Yosuke Kitagawa

  • Masashi Nomura

  • Shunsaku Takayanagi

  • Shota Tanaka

  • Nobuhito Saito

  • October 15, 2025

  • 0 min

Share

Original Source(s)

Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases

  • by Sukwoo Hong, Hirokazu Takami, Motoyuki Umekawa, Yuki Shinya, Hirotaka Hasegawa, Mariko Kawashima, Yosuke Kitagawa, Masashi Nomura, Shunsaku Takayanagi, Shota Tanaka, Nobuhito Saito

  • October 15, 2025

Related Content

Case Report: Extranodal marginal zone B-cell lymphoma in the lateral ventricle: literature review

Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review

Real-world comparison of BTK inhibitors and lenalidomide as first-line maintenance in primary CNS lymphoma: a multi-center retrospective study